1887

oa South African Medical Journal - Preliminary trial of a powerful new sulphonylurea in maturity-onset diabetes - HB419 (Glibenclamide)

 

Abstract

HB4l9 is a remarkably potent sulphonylurea, of which only a few milligrams are effective in sensitive maturity-onset diabetics.

Loading

Article metrics loading...

/content/m_samj/43/32/AJA20785135_33384
1969-08-01
2016-12-07
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error